81 related articles for article (PubMed ID: 22292623)
1. Role of hypercholesterolemia in prostate cancer--case control study from Manipal Teaching Hospital Pokhara, Nepal.
Mittal A; Sathian B; Chandrasekharan N; Lekhi A; Yadav SK
Asian Pac J Cancer Prev; 2011; 12(8):1905-7. PubMed ID: 22292623
[TBL] [Abstract][Full Text] [Related]
2. Metabolic changes enhance the cardiovascular risk with differentiated thyroid carcinoma--a case control study from Manipal Teaching Hospital of Nepal.
Mittal A; Poudel B; Pandeya DR; Gupta SP; Sathian B; Yadav SK
Asian Pac J Cancer Prev; 2012; 13(5):2335-8. PubMed ID: 22901217
[TBL] [Abstract][Full Text] [Related]
3. Role of hyperinsulinemia in increased risk of prostate cancer: a case control study from Kathmandu Valley.
Pandeya DR; Mittal A; Sathian B; Bhatta B
Asian Pac J Cancer Prev; 2014; 15(2):1031-3. PubMed ID: 24568446
[TBL] [Abstract][Full Text] [Related]
4. Prostate biomarkers with reference to body mass index and duration of prostate cancer.
Poudel B; Mittal A; Shrestha R; Nepal AK; Shukla PS
Asian Pac J Cancer Prev; 2012; 13(5):2149-52. PubMed ID: 22901185
[TBL] [Abstract][Full Text] [Related]
5. Improved diagnostic accuracy of pancreatic diseases with a combination of various novel serum biomarkers--case control study from Manipal Teaching Hospital, Pokhara, Nepal.
Farooqui MS; Mittal A; Poudel B; Mall SK; Sathian B; Tarique M; Farooqui MH
Asian Pac J Cancer Prev; 2012; 13(5):2171-4. PubMed ID: 22901189
[TBL] [Abstract][Full Text] [Related]
6. Ability of biochemical parameters to distinguish between bile duct cancer and gall bladder stones--a case control study in a tertiary care hospital of Pokhara Valley.
Yadav SK; Mittal A; Sapkota K; Gupta SP; Sathian B
Asian Pac J Cancer Prev; 2013; 14(2):817-9. PubMed ID: 23621244
[TBL] [Abstract][Full Text] [Related]
7. The influence of statin medications on prostate-specific antigen levels.
Hamilton RJ; Goldberg KC; Platz EA; Freedland SJ
J Natl Cancer Inst; 2008 Nov; 100(21):1511-8. PubMed ID: 18957682
[TBL] [Abstract][Full Text] [Related]
8. Assessment of atorvastatin effectiveness on serum PSA level in hypercholesterolemic males.
Khosropanah I; Falahatkar S; Farhat B; Heidari Bateni Z; Enshaei A; Allahkhah AA; Khosropanah D
Acta Med Iran; 2011; 49(12):789-94. PubMed ID: 22174166
[TBL] [Abstract][Full Text] [Related]
9. Plasma total, LDL, and HDL cholesterol and risk of aggressive prostate cancer in the Cancer Prevention Study II Nutrition Cohort.
Jacobs EJ; Stevens VL; Newton CC; Gapstur SM
Cancer Causes Control; 2012 Aug; 23(8):1289-96. PubMed ID: 22692409
[TBL] [Abstract][Full Text] [Related]
10. Assessment of biochemical profiles in premenopausal and postmenopausal women with breast cancer.
Yadav NK; Poudel B; Thanpari C; Chandra Koner B
Asian Pac J Cancer Prev; 2012; 13(7):3385-8. PubMed ID: 22994765
[TBL] [Abstract][Full Text] [Related]
11. Awareness and assessment of risk factors for lung cancer in residents of Pokhara Valley, Nepal.
Chawla R; Sathian B; Mehra A; Kiyawat V; Garg A; Sharma K
Asian Pac J Cancer Prev; 2010; 11(6):1789-93. PubMed ID: 21338234
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of carcinogenic embryonic antigen in differential diagnosis of diseases of pancreas and liver--a comparative study in a tertiary care hospital of Western Nepal.
Mittal A; Farooqui SM; Pyrtuh S; Poudel B; Sathian B; Yadav SK
Asian Pac J Cancer Prev; 2012; 13(1):275-7. PubMed ID: 22502684
[TBL] [Abstract][Full Text] [Related]
13. Body mass index and prostate specific antigen levels in Jamaican men.
Tulloch-Reid MK; Aiken WD; Morrison BF; Tulloch T; Mayhew R; Wan RL; Bennett FI; Coard KC; Jackson MD
West Indian Med J; 2011 Jun; 60(3):316-21. PubMed ID: 22224345
[TBL] [Abstract][Full Text] [Related]
14. Clinico-pathologic characterisation of metastatic prostate cancer in the Radiotherapy and Oncology Department, Ahmadu Bello University Teaching Hospital, Zaria-Nigeria: 2006-2009.
Adewuyi SA; Mbibu NH; Samaila MO; Ketiku KK; Durosinmi-Etti FA
Niger Postgrad Med J; 2013 Mar; 20(1):45-51. PubMed ID: 23661210
[TBL] [Abstract][Full Text] [Related]
15. Lipid profile of population of central region of Nepal.
Takhelmayum R; Thanpari C; Kumar S; Singh AR; Sinha JN
Mymensingh Med J; 2014 Jul; 23(3):552-7. PubMed ID: 25178609
[TBL] [Abstract][Full Text] [Related]
16. Hypercholesterolemia and prostate cancer: a hospital-based case-control study.
Magura L; Blanchard R; Hope B; Beal JR; Schwartz GG; Sahmoun AE
Cancer Causes Control; 2008 Dec; 19(10):1259-66. PubMed ID: 18704722
[TBL] [Abstract][Full Text] [Related]
17. Lipoproteins, sex hormones and inflammatory markers in association with prostate cancer.
Grosman H; Fabre B; Mesch V; Lopez MA; Schreier L; Mazza O; Berg G
Aging Male; 2010 Jun; 13(2):87-92. PubMed ID: 19921964
[TBL] [Abstract][Full Text] [Related]
18. Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer.
Hammarsten J; Högstedt B
Eur J Cancer; 2005 Dec; 41(18):2887-95. PubMed ID: 16243513
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic significance of alpha fetoprotein in carcinomas of liver and biliary tract - a comparative study from the western region of Nepal.
Mittal A; Sathian B; Chandrashekharan N; Farooqui SM; Hussain A
Asian Pac J Cancer Prev; 2011; 12(12):3475-8. PubMed ID: 22471500
[TBL] [Abstract][Full Text] [Related]
20. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
